Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

BACKGROUND: Immune checkpoint inhibiting antibodies were introduced into routine clinical practice for cancer patients. Checkpoint blockade has led to durable remissions in some patients, but may also induce immune-related adverse events (irAEs). Lung cancer patients show an increased risk for compl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Läubli, Heinz, Balmelli, Catharina, Kaufmann, Lukas, Stanczak, Michal, Syedbasha, Mohammedyaseen, Vogt, Dominik, Hertig, Astrid, Müller, Beat, Gautschi, Oliver, Stenner, Frank, Zippelius, Alfred, Egli, Adrian, Rothschild, Sacha I.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5964701/
https://ncbi.nlm.nih.gov/pubmed/29789020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0353-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados